HOME >> BIOLOGY >> NEWS
New mouse model closely mimics human cancers

BOSTON--A team led by Dana-Farber Cancer Institute scientists has developed a more human-like mouse model of cancer they say will aid the search for cancer-causing genes and improve the predictive value of laboratory drug testing.

Ronald A. DePinho, MD, of Dana-Farber has created mice that form tumors that are more genetically complex and unstable -- and therefore a better stand-in for human cancers -- than those of conventional genetically engineered mouse models of cancer. To characterize these mouse tumors, DePinho collaborated with Lynda Chin, MD, also at Dana-Farber, to perform high-resolution array-CGH profiling, a genome-scanning technology that can define regions of DNA abnormalities.

The report has been posted as an advanced online by the journal Nature and will appear in a forthcoming print version.

The scientists, working with a large dataset generated by the Chin laboratory during the past several years, compared the patterns of these chromosomal changes in the mice with patterns observed in more than 400 human tumor specimens, including melanoma, lung, colon, and pancreatic cancers, and multiple myeloma.

The comparisons showed that genetic instability in the mouse cancer cells caused DNA alterations that in many cases were identical to such changes in human tumors. This match up, said the researchers, suggested that the new mouse model may be useful in guiding the search for genes that are important for cancer growth. To that end, it may facilitate research associated with the National Institutes of Health-funded Human Cancer Genome Atlas Project, which involves sifting the entire human DNA and identifying the immensely complicated, interacting molecular changes that initiate and maintain tumors.

"We found a rather striking overlap of genetic alterations in the mouse and human cancers, which should greatly help us sort out genetic events that drive cancers from those that are simply irrelevant 'passe
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
24-May-2007


Page: 1 2 3

Related biology news :

1. OHSU turns mouse into factory for human liver cells
2. Virtual mouse brains now available online
3. New approaches to endometriosis treatment -- mouse experiments point the way
4. Statin treatment improves spatial memory in mouse models of Alzheimers
5. Treatment extends survival in mouse model of spinal muscular atrophy
6. UCSF stem cell study reveals cells capability in mouse brain tissue repair
7. Mutant mouse provides insights into breast cancer
8. Mapping the mouse genome
9. MRSA vaccine shows promise in mouse study
10. Researchers create mouse lacking key inflammation gene
11. U of MN researchers develop mouse model for muscle disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2019)... LOS ANGELES (PRWEB) , ... July 26, 2019 ... ... pleased to announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps ... or trauma. , Helius Medical Technologies is a neurotech company in ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... genetic counseling, today announced that the company has expanded its database of genetic ... familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded content comes following 23andMe’s ...
(Date:7/21/2019)... , ... July 20, 2019 ... ... Imaging Technologies ( http://www.fluidimaging.com ) announced today the release of the biggest ... particle imaging and characterization platform will provide a significant increase in productivity ...
Breaking Biology News(10 mins):
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , ... dialogue, today announces its Boston BD conference to be held on ... Biotech Week Boston , the event provides an opportunity for attendees to leverage ...
(Date:7/17/2019)... ... July 15, 2019 , ... CRISPR is often thought of as ... can be removed, replaced, or edited, but Yiping Qi, assistant professor in Plant Science ... applications in his latest publication in Nature Plants. In this comprehensive review, Qi and ...
(Date:7/9/2019)... ... ... Today, at the BIO World Congress on Industrial Biotechnology and ... the winners of the Consider Corn Challenge II. Three winners were chosen, each with ... biobased materials. , “Corn is a sustainable, abundant and affordable industrial feedstock ...
(Date:6/18/2019)... SOMERSET, N.J. (PRWEB) , ... June 17, 2019 ... ... today announced that they have entered into an agreement for production and manufacturing ... IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 ...
Breaking Biology Technology:
Cached News: